Researchers uncover cetuximab resistance pathway in bowel cancer
Researchers from Queen’s University, Belfast, have discovered that blocking a certain molecule could help side-step resistance to cetuximab in bowel cancer patients.
Read More
Tag: ADAM17
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
